Lung Neoplasms  >>  ispinesib (SB-715992)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ispinesib (SB-715992) / Cytokinetics
NCT00085813: Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung Cancer

Completed
2
70
US, Europe
Ispinesib
GlaxoSmithKline
Non-Small-Cell Lung Cancer
10/05
10/05

Download Options